Citi Trends - CTRN Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Citi Trends in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CTRN shares.
View CTRN analyst ratings or view top-rated stocks.

4 equities research analysts have issued 1 year price objectives for Citi Trends' stock. Their CTRN share price forecasts range from $34.00 to $60.00. On average, they expect the company's share price to reach $47.25 in the next twelve months. This suggests a possible upside of 43.3% from the stock's current price.
View analysts price targets for CTRN or view top-rated stocks among Wall Street analysts.

Citi Trends' stock was trading at $94.75 on January 1st, 2022. Since then, CTRN stock has decreased by 65.2% and is now trading at $32.97.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 24th 2022.
View our CTRN earnings forecast.

Citi Trends will be holding an earnings conference call on Wednesday, August 24th at 9:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 402-977-9140 with passcode "22019378".

Citi Trends, Inc. (NASDAQ:CTRN) released its quarterly earnings results on Tuesday, May, 24th. The company reported $0.42 earnings per share for the quarter, beating analysts' consensus estimates of $0.34 by $0.08. The business earned $208.22 million during the quarter, compared to analysts' expectations of $207.10 million. Citi Trends had a net margin of 6.73% and a trailing twelve-month return on equity of 27.43%. During the same period in the prior year, the company posted $3.23 earnings per share.

Citi Trends updated its FY 2022 earnings guidance on Tuesday, June, 21st. The company provided earnings per share guidance of $2.25-$2.75 for the period, compared to the consensus earnings per share estimate of $3.52. The company issued revenue guidance of $860.00 million-$880.00 million, compared to the consensus revenue estimate of $914.83 million.

Based on aggregate information from My MarketBeat watchlists, some companies that other Citi Trends investors own include Citigroup (C), Tapestry (TPR), Tesla (TSLA), Verizon Communications (VZ), International Business Machines (IBM), Pfizer (PFE), Walgreens Boots Alliance (WBA), Wells Fargo & Company (WFC), AbbVie (ABBV) and Broadcom (AVGO).

Citi Trends trades on the NASDAQ under the ticker symbol "CTRN."

Citi Trends' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (11.53%), Jennison Associates LLC (6.30%), Paradigm Capital Management Inc. NY (5.56%), Millennium Management LLC (3.02%), State Street Corp (1.92%) and Cambria Investment Management L.P. (1.67%). Insiders that own company stock include Charles J Hynes, Christina M Francis, Christina Short, David N Makuen, Ivy D Council, James A Dunn, James A Dunn, Jason Moschner, Jessica Berkowitz, Jonathan Duskin, Kenneth Duane Seipel, Lisa A Powell, Margaret L Jenkins and Peter R Sachse.
View institutional ownership trends.

Shares of CTRN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CTRN stock can currently be purchased for approximately $32.97.

Citi Trends (NASDAQ:CTRN) has a market capitalization of $276.78 million and generates $991.59 million in revenue each year. The company earns $62.24 million in net income (profit) each year or $7.14 on an earnings per share basis.

The company employs 5,400 workers across the globe.

Citi Trends was founded in 1946.

Citi Trends' mailing address is 104 COLEMAN BOULEVARD, SAVANNAH GA, 31408. The official website for the company is www.cititrends.com. The company can be reached via phone at (912) 236-1561 or via fax at 912-443-3663.